Abstract:Objective: To explore the gene mutation characteristics and detailed clinical presentations of hyperglycemia caused by GCK mutations in 10 patients. Methods: The clinical and follow-up data of 10 patients with hyperglycemia caused by mutation of GCK gene were reviewed. The patients were ascertained between January 1, 2014 and August 31, 2018 at the Department of Pediatrics, the First Affiliated Hospital of Zhejiang University and Ningbo Women & Children's Hospital. Clinical data were collected, including age, gender, main complaint, family history, fasting blood glucose, fasting blood insulin, 2-hour blood glucose, 2-hour blood insulin after oral glucose tolerance test, glycosylated hemoglobin, anti-glutamic acid decarboxylase antibody and body mass index. Mutations of GCK gene were detected by Sanger sequencing or high-throughput sequencing of diabetes-related genes in the patients and their family members. Results: There were ten patients, 8 of them were male, 2 were female.The ages at diagnosis varied between 4.7 to 12.3 years. The patients usually did not have obvious clinical symptoms of diabetes mellitus. Most of them were unexpectedly found to have hyperglycemia and with impaired glucose metabolism in three consecutive generations. The fasting blood glucose of patients was 6.8-7.7 mmol/L, 2-hour postprandial blood glucose was 7.8-11.6 mmol/L. Fasting blood insulin was 0.5-8.5 mU/L, glucose tolerance test results showed that 2 h postprondial blood insulin was 1.3-55.4 mU/L. The level of glycosylated hemoglobin was 6.1%-6.8%. Anti-glutamic acid decarboxylase antibody was negative in all patients. The GCK mutations identified in patients and one of their parents were located at exon5 (4 cases), exon9 (2 cases), exon2 (1 case), exon4 (1 case), exon6 (1 case) and exon7 (1 case). Conclusions: Most of the hyperglycemia patients caused by GCK mutations did not have typical clinical symptoms of diabetes. The fasting blood glucose was slightly elevated. Abnormal glucose tolerance test results were found in all 10 patients. Three consecutive generations of family had impaired glucose metabolism. GCK mutations located at exon 5 were common in 10 cases. There was no correlation between type of mutations and plasma glucose levels in domestic and international researches. When fasting glucose was found abnormal in clinic, a complete family history should be taken and the GCK gene should be sequenced to confirm the diagnosis in time.

Mutation analysis of GCDH gene in eight patients with glutaric aciduria type I]

Clinical and Mutational Spectra of 23 Chinese Patients with Glutaric Aciduria Type 1.

[Clinical and Genetic Analyses of a Family with Atypical Nonketotic Hyperglycinemia Caused by Compound Heterozygous Mutations in the GLDC Gene].

Clinical features and GCDH gene variants in three Chinese families with glutaric aciduria type 1: A case series and literature review

Mutation Analysis of Ganglioside-Induced Differentiation Associated Protein-1 Gene in Chinese Charcot-Marie-Tooth Disease

[Hyperglycemia Caused by Mutation of GCK Gene in 10 Patients Analysis of Clinical and Mutation Characteristics].

[Clinical and Laboratory Studies on 28 Patients with Glutaric Aciduria Type 1].

The characteristics of gene mutations in Chinese patients with Charcot-Marie-Tooth disease]

Analysis of MUT gene mutations in a patient with isolated methylmalonic acidemia]

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia

[Clinical Features and Acid Alpha-Glucosidase Gene Mutation in 7 Chinese Patients with Glycogen Storage Disease Type II].

Identification of Eight Novel Mutations of the Acid Α-Glucosidase Gene Causing the Infantile or Juvenile Form of Glycogen Storage Disease Type II

[Analysis of GFM1 Gene Mutations in a Family with Combined Oxidative Phosphorylation Deficiency 1].

[AGL gene analysis of a pedigree with glycogen storage disease type III and identification of a novel mutation]

Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation

The Pathogenicity of Novel GUCY2D Mutations in Leber Congenital Amaurosis 1 Assessed by HPLC-MS/MS.

Prenatal Diagnosis of Glutaric Acidemia I Based on Amniotic Fluid Samples in 42 Families Using Genetic and Biochemical Approaches

Molecular genetics of glycogen-storage disease type 1a in Chinese patients of Taiwan

Cinical treatment of 3-hydroxy-3-methylglutaric aciduria and a novel mutation on 3-hydroxy-3-methylglutaryl-coenzyme A lyase gene

Novel compound heterozygous missense mutations in GDAP1 cause Charcot–Marie–Tooth type 4A

Two inborn errors of metabolism in a newborn: glutaric aciduria type I combined with isobutyrylglycinuria